dc.contributorGómez Mazuera, Angela
dc.contributorForero-Botero, Cesar A.
dc.creatorJaramillo Herrera, Diana Patricia
dc.date.accessioned2020-10-21T18:24:19Z
dc.date.available2020-10-21T18:24:19Z
dc.date.created2020-10-21T18:24:19Z
dc.identifierhttps://doi.org/10.48713/10336_30437
dc.identifierhttps://repository.urosario.edu.co/handle/10336/30437
dc.description.abstractA case of lower motor neuron disease is described, probably of paraneoplastic origin associated with follicular B cell lymphoma. Lower motor neuron disease is not one of the most common paraneoplastic neurological syndromes but is strongly associated with lymphomas. In this case the clinical findings of motor neuron disease started with generalized fasciculations, muscle atrophy with weakness in upper limbs and split hand deformity, also mild dysphonia. All this symptoms and findings could be consistent with primary motor neuron disease. There was no relationship with polyneuropathy because the nerve conductions did not show any alteration in sensory action potentials or blockages in motor nerve conduction. However, electromyography did clearly show a neuropathic pattern with marked denervation activity in the four spinal segments. Extension studies were carried out to exclude other conditions and thus establish primary motor neuron disease; nevertheless, multiple mediastinal nodes were reported on a chest tomography scan and hypermetabolic nodes were documented on the PET-Scan which clarified a baseline diagnosis. The patient received chemotherapy with stabilization of lower motor neuron syndrome.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherFacultad de Medicina
dc.publisherEspecialización en Neurofisiología Clínica
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceMélé N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N, et al. Motor neuron disease of paraneoplastic origin: a rare but treatable condition. J Neurol [Internet]. 2018;265(7):1590–9. Available from: http://dx.doi.org/10.1007/s00415-018-8881-0
dc.sourceCorcia P, Gordon PH, Camdessanche JP. Is there a paraneoplastic ALS? Amyotroph Lateral Scler Front Degener. 2015;16(3–4):252–7.
dc.sourceAkan O, Baysal-Kirac L. Amyotrophic lateral sclerosis with coexisting cancer: a single-center study. Acta Neurol Belg [Internet]. 2020;(0123456789). Available from: https://doi.org/10.1007/s13760-020-01337-y
dc.sourceRosenfeld MR, Dalmau J. Paraneoplastic Neurologic Syndromes. Neurol Clin [Internet]. 2018;36(3):675–85. Available from: https://doi.org/10.1016/j.ncl.2018.04.015
dc.sourceZoccarato M, Gastaldi M, Zuliani L, Biagioli T, Brogi M, Bernardi G, et al. Diagnostics of paraneoplastic neurological syndromes. Neurol Sci. 2017;38:237–42.
dc.sourceBraik T, Evans AT, Telfer M, McDunn S. Paraneoplastic neurological syndromes: Unusual presentations of cancer. A practical review. Am J Med Sci [Internet]. 2010;340(4):301–8. Available from: http://dx.doi.org/10.1097/MAJ.0b013e3181d9bb3b
dc.sourceIorio R, Spagni G, Masi G. Paraneoplastic neurological syndromes. Semin Diagn Pathol [Internet]. 2019;36(4):279–92. Available from: https://doi.org/10.1053/j.semdp.2019.06.005
dc.sourceBerzero G, Psimaras D. Neurological paraneoplastic syndromes: An update. Curr Opin Oncol. 2018;30(6):359–67.
dc.sourceZidan A, Fein A, Zuchowski K. The use, misuse and abuse of paraneoplastic panels in neurological disorders. A retrospective study. Clin Neurol Neurosurg [Internet]. 2019;186(July):105545. Available from: https://doi.org/10.1016/j.clineuro.2019.105545
dc.sourceGoodfellow J, Gorrie G, Leach V, Patel S, Mackay G. Cancer and motor neuron disease—causal or coincidental? Two contrasting cases. Neurol Sci. 2019;40(7):1461–3.
dc.sourceBriani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76(8):705–10.
dc.sourceVerschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci [Internet]. 2015;358(1–2):413–6. Available from: http://dx.doi.org/10.1016/j.jns.2015.08.014
dc.sourceVerschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S, et al. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci [Internet]. 2015;358(1–2):413–6. Available from: https://doi.org/10.1016/j.jns.2019.01.029
dc.sourceGiometto B, Vitaliani R, Lindeck-Pozza E, Grisold W, Vedeler C. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev. 2009;(1).
dc.sourceGrativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes. Curr Oncol Rep. 2018;20(11).
dc.sourceLeypoldt F, Wandinger KP. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175(3):336–48.
dc.sourceAntoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol. 2017;30(5):513–20
dc.sourceTurk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, et al. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2008;18(1):73–5.
dc.sourceMuppidi S, Vernino S. Paraneoplastic neuropathies. Contin Lifelong Learn Neurol. 2014;20(5):1359–72.
dc.sourceVigliani MC, Polo P, Chiò A, Giometto B, Mazzini L, Schiffer D. Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis. J Neurol. 2000;247(10):778–82.
dc.sourcePinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep. 2018;20(4)
dc.sourceYounger DS, Rowland LP, Latov N, Hays AP, Lange DJ, Sherman W, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol. 1991;29(1):78–86
dc.sourceRowland LP, Gordon PH, Younger DS, Sherman WH, Hays AP, Louis ED, et al. Lymphoproliferative disorders and motor neuron disease. Neurology. 1998;50(2):576
dc.sourceLa Bella V, Iannitto E, Cuffaro L, Spataro R. A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia. J Neurol Sci [Internet]. 2019;398(December 2018):117–8. Available from: https://doi.org/10.1016/j.jns.2019.01.029
dc.sourceKepp KP. Genotype-property patient-phenotype relations suggest that proteome exhaustion can cause amyotrophic lateral sclerosis. PLoS One. 2015;10(3):1–19.
dc.sourceBlizzard CA, Southam KA, Dawkins E, Lewis KE, King AE, Clark JA, et al. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - Vulnerability of lower motor neurons to proximal excitotoxicity. DMM Dis Model Mech. 2015;8(3):215–24.
dc.sourceDo-Ha D, Buskila Y, Ooi L. Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy. Mol Neurobiol. 2018;55(2):1410–8.
dc.sourceHerrero S, Cantalapiedra A, Pérez-Oteyza J, Bellas C, Gobernado J, Ordiozola J. Mantle cell lymphoma with amyotrophic lateral sclerosis (motor neuron disease). Haematologica [Internet]. 2006;91(9):2007–9. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16963398
dc.sourceHigashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S. Motor neuron disease with malignancy: Clinical and pathophysiological insights. Clin Neurophysiol [Internet]. 2019;130(9):1557–61. Available from: https://doi.org/10.1016/j.clinph.2019.05.026
dc.sourceStruck AF, Salamat S, Waclawik AJ. Motor neuron disease with selective degeneration of anterior horn cells associated with non-hodgkin lymphoma. J Clin Neuromuscul Dis. 2014;16(2):83–9.
dc.sourceArgyriou AA, Park SB, Islam B, Tamburin S, Velasco R, Alberti P, et al. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings. J Neurol Neurosurg Psychiatry. 2019;1–9.
dc.sourceChan AM, Baehring JM. Paraneoplastic neurological syndromes: a single institution 10-year case series. J Neurooncol [Internet]. 2019;141(2):431–9. Available from: http://dx.doi.org/10.1007/s11060-018-03053-3
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectSíndrome neurológico paraneoplásico
dc.subjectEnfermedad de motoneurona
dc.subjectSíndrome de motoneurona inferior
dc.subjectAutoanticuerpos neurales
dc.subjectAnticuerpos onconeurales
dc.subjectAnticuerpos de superficie
dc.subjectLinfoma
dc.titleSíndrome Neurológico Paraneoplásico: Enfermedad de neurona motora inferior, reporte de un caso
dc.typemasterThesis


Este ítem pertenece a la siguiente institución